Spevigo: how long were the pivotal tox studies?

“BI 674304 was evaluated in a pivotal 26-week repeat-dose general toxicity study in CD-1 mice.”

“BI 674304 was evaluated in a pivotal 26-week repeat-dose general toxicity study in CD-1 mice. BI 674304 was administered via intravenous injection, twice weekly, at the doses of 0, 10, and 50 mg/kg.”

“BI 674304 was administered via intravenous injection, twice weekly, at the doses of 0, 10, and 50 mg/kg.”